Prof. Dr. Mutlu Demiray

Internal Medicine and Medical Oncology Specialist · Genomic Oncology
Director, Medicana Personalized Cancer Treatment Center

As a medical professional deeply committed to advancing patient care and transforming the landscape of oncology, Prof. Dr. Mutlu Demiray's clinical focus is precision oncology. Throughout his career he has devoted himself to unraveling the intricacies of cancer biology and harnessing Next-Generation Sequencing (NGS) technologies to transform cancer treatment.

His primary focus is the meticulous analysis of patients' NGS results, which allows him to unlock invaluable insights into the unique biology of their tumors. With this personalized approach he designs tailored treatment regimens that address the specific molecular aberrations driving each individual's cancer, maximizing therapeutic efficacy while minimizing adverse effects.

His passion for precision oncology drives him to explore novel therapeutic avenues, collaborate with multidisciplinary teams, and contribute significantly to the ever-evolving landscape of personalized cancer care.

Another of his core interests is integrative oncology: he evaluates traditional treatment methods at the molecular level and applies them together with modern treatments in the way most beneficial to his patients.